At CureSearch, our success is measured by how quickly a new therapy reaches a child, because our kids can’t wait for more effective, less toxic treatments.
Our preclinical projects are 5 times more likely than average to advance into clinical trials, and they reach the clinic more than 2 years faster. That speed is critical for families facing cancers with the lowest survival rates and fewest treatment options.
With your support, we’ve accelerated the development of innovative childhood cancer treatments at leading institutions across the country including:
- A cutting-edge trial currently enrolling pediatric glioma patients at 6 sites across the country
- An upcoming clinical trial for high-grade glioma patients at the University of Florida Shands Children’s Hospital
- Testing a promising new treatment for the deadly brain tumor DIPG in a clinical trial at Stanford University
- Identifying promising new therapies for pediatric sarcoma at Memorial Sloan Kettering Cancer Center
This critical research is only possible with your support. Will you give this holiday season and help deliver better treatments to the kids who are counting on us?Donate Now